UK markets closed

Brainstorm Cell Therapeutics Inc. (GHDN.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.3695-0.0215 (-5.50%)
At close: 09:06AM CEST
Show:
Income statement
Balance sheet
Annual

Cash flow

Currency in USD. All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-16,632
-24,277
-24,457
-31,811
-23,253
Depreciation & amortisation
269
285
260
219
164
Stock-based compensation
1,917
1,682
1,366
2,560
764
Change in working capital
-614
2,990
-3,434
-6,161
11,053
Accounts receivable
-
-
-
-
690
Accounts payable
-469
2,524
-1,717
-9,260
10,129
Other working capital
-21,839
-19,349
-26,595
-35,571
-11,720
Other non-cash items
-
-
-
161
25
Net cash provided by operating activities
-21,821
-19,320
-26,265
-35,193
-11,247
Cash flows from investing activities
Investments in property, plant and equipment
-18
-29
-330
-378
-473
Net cash used for investing activities
3,035
998
323
-4,452
5,616
Cash flows from financing activities
Common stock issued
15,864
238
6,964
60,729
2,064
Common stock repurchased
-
-
0
-116
0
Net cash used provided by (used for) financing activities
15,864
238
6,969
76,938
5,225
Net change in cash
-2,922
-18,084
-18,973
37,293
-406
Cash at beginning of period
4,144
18,856
37,829
536
942
Cash at end of period
1,222
772
18,856
37,829
536
Free cash flow
Operating cash flow
-21,821
-19,320
-26,265
-35,193
-11,247
Capital expenditure
-18
-29
-330
-378
-473
Free cash flow
-21,839
-19,349
-26,595
-35,571
-11,720